Supporting clinical management of the difficult-to-treat TB cases: The ERS-WHO TB Consilium

International Journal of Infectious Diseases

Volumn 32, Issue , 2015, Pages 156-160

  D'Ambrosio, Lia ^a   Tadolini, Marina ^b   Centis, Rosella ^a   Duarte, Raquel ^c   Sotgiu, Giovanni ^d   Aliberti, Stefano ^e   Dara, Masoud ^a   Migliori, Giovanni Battista ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c Pneumologia Centro de Diagnóstico Pneumológico   (Portugal)

^d UNIVERSITY OF SASSARI   (Italy)

^e UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Clinical management; Drug resistance; ERS WHO Consilium; MDR TB; Prevention; XDR TB

Indexed keywords

TUBERCULOSTATIC AGENT;

ARTICLE; CLINICAL PRACTICE; CONSULTATION; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; EXTRAPULMONARY TUBERCULOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; LUNG TUBERCULOSIS; MIXED INFECTION; MULTIDRUG RESISTANT TUBERCULOSIS; OUTCOME ASSESSMENT; PATHOGEN CLEARANCE; PUBLIC HEALTH; USSR; WORLD HEALTH ORGANIZATION; ADOLESCENT; ADULT; AGED; CHILD; DISEASE MANAGEMENT; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; FEMALE; INFANT; MALE; MIDDLE AGED; PRESCHOOL CHILD; TELECONSULTATION; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; DISEASE MANAGEMENT; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; PUBLIC HEALTH; REMOTE CONSULTATION; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT; WORLD HEALTH ORGANIZATION; YOUNG ADULT;

EID: 84922996783     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2014.12.024     Document Type: Article

References (28)

1. Raviglione M., Marais B., Floyd K., Lönnroth K., Getahun H., Migliori G.B., et al. Scaling up interventions to achieve global tuberculosis control: progress and new developments. Lancet 2012, 379:1902-1913.
2. Global Tuberculosis Report 2014. Document WHO/HTM/TB/2014. 08 2014, World Health Organization, World Health Organization, Geneva.
3. Zignol M., van Gemert W., Falzon D., et al. Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007-2010. Bull World Health Organ. 2012 Feb 1, 90(2):111.
4. Matteelli A., Centis R., D'Ambrosio L., Migliori G.B. Multidrug-resistant tuberculosis today. Bull World Health Organ. 2012, 90(2):78.
5. Abubakar I., Dara M., Manissero D., Zumla A. Tackling the spread of drug-resistant tuberculosis in Europe. Lancet 2012, 379:e21-e23.
6. Dara M, Kluge H. Roadmap to prevent and combat drug-resistant tuberculosis. Copenhagen, World Health Organization, Regional Office for Europe, 2011. Last access 28 October 2014 2012. http://www.euro.who.int/__data/assets/pdf_file/0014/152015/e95786.pdf.
7. Skrahina A., Hurevich H., Zalutskaya A., Sahalchyk E., Astrauko A., van Gemert W., et al. Alarming levels of drug-resistant tuberculosis in Belarus: results of a survey in Minsk. Eur Respir J 2012, 39:1425-1431.
8. Migliori G.B., Dara M., de Colombani P., Kluge H., Raviglione M.C. Multidrug-resistant tuberculosis in Eastern Europe: still on the increase?. Eur Respir J 2012, 39:1290-1291.
9. Towards universal access to diagnosis and treatment of multidrug-resistant and extensively drug-resistant tuberculosis by 2015: WHO progress report 2011. Document WHO/HTM/TB/2011.3 2011, World Health Organization, World Health Organization, Geneva.
10. Tuberculosis surveillance and monitoring in Europe 2012 2012, European Centre for Disease Prevention AND Control/WHO Regional Office for Europe, European Centre for Disease Prevention and Control, Stockholm.
11. Ahuja S.D., Ashkin D., Avendano M., et al. Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients. PLoS Med. 2012 Aug, 9(8):e1001300. Epub 2012 Aug 28.
12. Falzon D., Gandhi N., Migliori G.B., Sotgiu G., Cox H., Holtz T.H., et al. Resistance to fluoroquinolones and second-line injectable drugs: impact on MDR-TB outcomes. Eur Respir J. 2013 Jul, 42(1):156-168.
13. Migliori G.B., Sotgiu G., Gandhi N.R., Falzon D., DeRiemer K., Centis R., et al. Drug resistance beyond XDR-TB: results from a large individual patient data meta-analysis. Eur Respir J 2012, The Collaborative Group for Meta-Analysis of Individual Patient Data in MDR-TB, erj01363-2012; published ahead of print. 10.1183/09031936.00136312.
14. Migliori G.B., Sotgiu G., D'Ambrosio L., Centis R., Lange C., Bothamley G., et al. TB and MDR/XDR-TB in European Union and European Economic Area countries: managed or mismanaged?. Eur Respir J 2012, 39:619-625.
15. Falzon D., Jaramillo E., Schünemann H.J., Arentz M., Bauer M., Bayona J., et al. WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Eur Respir J 2011, 38:516-528.
16. Migliori G.B., Zellweger J.P., Abubakar I., Ibraim E., Caminero J.A., De Vries G., et al. European Union Standards for Tuberculosis Care. Eur Respir J. 2012, 39(4):807-819.
17. van der Werf Marieke J., Sandgren Andreas, D'Ambrosio Lia, Blasi Francesco, Migliori Giovanni Battista The European Union standards for tuberculosis care: do they need an update?. Eur Respir J 2014, 43:933-942.
18. Veen J., Migliori G.B., Raviglione M.C., Rieder H.L., Dara M., Falzon D., et al. Harmonisation of TB control in the WHO European region: the history of the Wolfheze Workshops. Eur Respir J 2011, 37:950-959.
19. Framework for tuberculosis elimination in low-incidence countries. Document WHO/HTM/TB/2014.13 2014, World Health Organization, World Health Organization, Geneva.
20. Diel R., Loddenkemper R., Zellweger J.P., Sotgiu G., D'Ambrosio L., Centis R., et al. European Forum for TB Innovation. Old ideas to innovate tuberculosis control: preventive treatment to achieve elimination. Eur Respir J. 2013 Sep, 42(3):785-801.
21. D'Ambrosio L., Dara M., Tadolini M., Centis R., Sotgiu G., van der Werf M.J., et al. TB Elimination: theory and practice in Europe. Eur Respir J 2014, 43:1410-1420. on behalf of the European national programme representatives.
22. Voniatis C., Migliori G.B., Voniatis M., Georgiou A., D'Ambrosio L., Centis R., et al. Tuberculosis elimination: dream or reality? The case of Cyprus. Eur Respir J 2014, 44:543-546.
23. Blasi F., Barnes P.J., Gaga M., Migliori G.B. Future directions for the ERS: presidential plans. Eur Respir J. 2013 Oct, 42(4):875-880.
24. Blasi F., Reichman L.B., Migliori G.B. Presenting the European Forum for TB Innovation: innovative thinking in progressing towards TB elimination in Europe. Eur Respir J. 2012, 40(4):806-808.
25. Migliori G.B., Sotgiu G., Blasi F., Zumla A., Loddenkemper R., Raviglione M.C., et al. Towards the development of EU/EEA Standards for Tuberculosis Care (ESTC). Eur Respir J 2011, 38:493-495.
26. D'Ambrosio L., Tadolini M., Dupasquier S., Tiberi S., Centis R., Dara M., et al. ERS/WHO TB consilium: reporting on initial 10 cases. Eur Respir J. 2014 Jan, 43(1):286-289.
27. Esposito S., D'Ambrosio L., Tadolini M., Schaaf H.S., Caminero Luna J., Marais M., et al. European Respiratory Society/World Health Organization Tuberculosis Consilium assistance with extensively drug-resistant tuberculosis management in a child: case study of compassionate delamanid use. Eur Respir J 2014, in press.
28. Codecasa L.R., Ciconali G., Mazzola E., Ferrarese M., Cirillo D.M., Borroni E., et al. and Marino Faccini. Managing an XDR-TB outbreak: the public health face of the medal. Eur Respir J 2014, in press.